BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 2123152)

  • 1. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
    Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M
    Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism.
    Diehl JL; Meyer G; Igual J; Collignon MA; Giselbrecht M; Even P; Sors H
    Am J Cardiol; 1992 Dec; 70(18):1477-80. PubMed ID: 1442621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new short infusion dosage regimen of recombinant tissue plasminogen activator in patients with venous thromboembolic disease.
    Levine MN; Weitz J; Turpie AG; Andrew M; Cruickshank M; Hirsh J
    Chest; 1990 Apr; 97(4 Suppl):168S-171S. PubMed ID: 2108854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
    Goldhaber SZ; Agnelli G; Levine MN
    Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
    Goldhaber SZ; Kessler CM; Heit JA; Elliott CG; Friedenberg WR; Heiselman DE; Wilson DB; Parker JA; Bennett D; Feldstein ML
    J Am Coll Cardiol; 1992 Jul; 20(1):24-30. PubMed ID: 1607532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bolus, front-loaded, and accelerated thrombolytic infusions for myocardial infarction and pulmonary embolism.
    Levine MN
    Chest; 1991 Apr; 99(4 Suppl):128S-134S. PubMed ID: 2009809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis.
    Zhang Z; Zhai ZG; Liang LR; Liu FF; Yang YH; Wang C
    Thromb Res; 2014 Mar; 133(3):357-63. PubMed ID: 24412030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial.
    Sors H; Pacouret G; Azarian R; Meyer G; Charbonnier B; Simonneau G
    Chest; 1994 Sep; 106(3):712-7. PubMed ID: 8082346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators.
    Chest; 1990 Mar; 97(3):528-33. PubMed ID: 2106408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model.
    Lu HR; Lijnen HR; Stassen JM; Collen D
    Blood; 1991 Jul; 78(1):125-31. PubMed ID: 1906351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion.
    Goldhaber SZ; Haire WD; Feldstein ML; Miller M; Toltzis R; Smith JL; Taveira da Silva AM; Come PC; Lee RT; Parker JA
    Lancet; 1993 Feb; 341(8844):507-11. PubMed ID: 8094768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.
    Agnelli G; Iorio A; Parise P; Goldhaber SZ; Levine MN
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):216-22. PubMed ID: 9199818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning.
    Parker JA; Markis JE; Palla A; Goldhaber SZ; Royal HD; Tumeh S; Kim D; Rustgi AK; Holman BL; Kolodny GM
    Radiology; 1988 Feb; 166(2):441-5. PubMed ID: 3122266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.
    Kucher N; Boekstegers P; Müller OJ; Kupatt C; Beyer-Westendorf J; Heitzer T; Tebbe U; Horstkotte J; Müller R; Blessing E; Greif M; Lange P; Hoffmann RT; Werth S; Barmeyer A; Härtel D; Grünwald H; Empen K; Baumgartner I
    Circulation; 2014 Jan; 129(4):479-86. PubMed ID: 24226805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.
    Wang C; Zhai Z; Yang Y; Wu Q; Cheng Z; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH;
    Chest; 2010 Feb; 137(2):254-62. PubMed ID: 19741062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bolus thrombolysis in pulmonary embolism. Review of experimental and clinical data].
    Zonzin P; Roncon L; Carraro M
    Ann Ital Med Int; 1996; 11(2):132-7. PubMed ID: 8974439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension. Effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics.
    Prewitt RM; Shiffman F; Greenberg D; Cook R; Ducas J
    Circulation; 1989 Apr; 79(4):929-38. PubMed ID: 2494007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.
    Tebbe U; Graf A; Kamke W; Zahn R; Forycki F; Kratzsch G; Berg G
    Am Heart J; 1999 Jul; 138(1 Pt 1):39-44. PubMed ID: 10385761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.
    Konstantinides S; Geibel A; Heusel G; Heinrich F; Kasper W;
    N Engl J Med; 2002 Oct; 347(15):1143-50. PubMed ID: 12374874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.